Screening For Cardiovascular Disease In Less Than 5 Minutes

A groundbreaking product from Panasonic Biomedical looks set to revolutionise medical screening for cardiovascular disease in the UK and Europe. Already successfully deployed in the United States, the GM-72P00A CardioHealth Station has been intelligently designed to look beyond just the traditionally considered cardiovascular risk factors, and uses a combination of subject test results analysis to provide a quick and reliable indicator of cardio health risk.

The CardioHealth Station integrates results from patient blood pressure tests, lipid testing, ankle-brachial pressure index and body measurements, and incorporates established cardiac risk assessment methods including the Framingham criteria, PROCAM risk scores, and the SCORE (Systematic Coronary Risk Evaluation) system.

However, the Panasonic CardioHealth Station also uses cutting edge technology to go one step beyond those established techniques. With an integrated ultrasonic imager, the unit allows healthcare professionals to easily perform a fully automated real time carotid intima-media thickness (C-IMT) measurement — in just five minutes.

C-IMT uses ultrasound technology to determine carotid artery wall thickness and the presence of arterial plaque — powerful indicators of potential risk in screening for cardiovascular disease. Panasonic has developed this product in consultation with key opinion leaders in the fields of preventive cardiology and the digital imaging of subclinical atherosclerosis.

The CardioHealth Station is designed for ease of use with minimal operator training, and incorporates a high resolution touch screen. Output reports can be provided directly to the patient, and are designed to be clear and easy to understand. The printout contains both actual ultrasound scan images, and computer-rendered schematic views that can help demonstrate arterial wall thickness and the presence of plaque. By providing a visual depiction of potential risk factors, healthcare professionals can help improve patient compliance with medical treatment or lifestyle recommendations.

Early identification of patients at risk of cardiovascular disease is a positive step forward not only in saving and improving the quality of people’s lives, it can also manifest genuine cost savings in a healthcare arena where every penny counts — and where it’s accepted as a maxim that prevention is better than cure.

Date added: 2015-05-25 12:07:56